TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Navinci Diagnostics AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
921
|
706
|
510 |
| Financial expenses |
47
|
80
|
0 |
| Earnings before taxes |
-3,540
|
-2,998
|
-2,033 |
| EBITDA |
-3,496
|
-2,964
|
-2,008 |
| Total assets |
3,260
|
4,880
|
3,488 |
| Current assets |
2,847
|
4,631
|
3,401 |
| Current liabilities |
600
|
792
|
463 |
| Equity capital |
2,660
|
4,088
|
3,026 |
| - share capital |
252
|
128
|
104 |
| Employees (average) |
24
|
24
|
18 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
81.6%
|
83.8%
|
86.8% |
| Turnover per employee |
38
|
29
|
28 |
| Profit as a percentage of turnover |
-384.4%
|
-424.6%
|
-398.6% |
| Return on assets (ROA) |
-107.1%
|
-59.8%
|
-58.3% |
| Current ratio |
474.5%
|
584.7%
|
734.6% |
| Return on equity (ROE) |
-133.1%
|
-73.3%
|
-67.2% |
| Change turnover |
239
|
195
|
387 |
| Change turnover % |
35%
|
38%
|
316% |
| Chg. No. of employees |
0
|
6
|
7 |
| Chg. No. of employees % |
0%
|
33%
|
64% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.